share_log

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga ·  Oct 18, 2024 00:30

Gainers

  • Tevogen Bio Holdings (NASDAQ:TVGN) shares increased by 109.6% to $2.18 during Thursday's regular session. The company's market cap stands at $371.9 million.
  • Molecular Templates (NASDAQ:MTEM) stock increased by 61.42% to $0.52. The market value of their outstanding shares is at $3.4 million.
  • Kazia Therapeutics (NASDAQ:KZIA) stock increased by 37.97% to $0.46. The company's market cap stands at $13.7 million.
  • Talphera (NASDAQ:TLPH) stock rose 36.93% to $1.14. The company's market cap stands at $19.3 million.
  • Sonnet BioTherapeutics (NASDAQ:SONN) stock increased by 27.16% to $6.46. The company's market cap stands at $33.6 million.
  • P3 Health Partners (NASDAQ:PIII) stock increased by 25.11% to $0.46. The market value of their outstanding shares is at $74.8 million.

Losers

  • Biodexa Pharmaceuticals (NASDAQ:BDRX) stock declined by 33.9% to $5.55 during Thursday's regular session. The market value of their outstanding shares is at $80.5 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock declined by 31.23% to $4.45. The company's market cap stands at $4.5 million.
  • Verastem (NASDAQ:VSTM) stock fell 19.67% to $2.67. The market value of their outstanding shares is at $107.6 million.
  • Cerus (NASDAQ:CERS) shares declined by 18.24% to $1.47. The market value of their outstanding shares is at $272.7 million.
  • Renovaro (NASDAQ:RENB) stock fell 15.52% to $0.79. The company's market cap stands at $123.2 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares decreased by 14.99% to $0.67. The company's market cap stands at $2.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment